Sign in

NCT04033718Completed

Inpatient Package to Reduce HIV and AIDS-related Death in Zambia

Source: ClinicalTrials.gov · Last updated 9 Aug 2024

Brief summary (registry, in English)

Early post-discharge mortality is high among HIV-infected Zambians admitted to the hospital. Likely this is in part due to missed opportunities to identify lethal coinfections and optimize HIV care during admission (and before discharge). In this study the investigators will develop and pilot a new approach to inpatient HIV care that follows international guidelines for management of advanced HIV disease.

Status (registry)
Completed
Study type
Interventional
Enrollment
72 (actual)
First submitted
23 Jul 2019
Start date
1 Oct 2021
Primary completion date
30 Jun 2024
Lead sponsor
University of Alabama at Birmingham
Diseases
Tuberculosis, HIV
NCT number
NCT04033718

What you commit to

  • Study type: Interventional
  • Participants enrolled: 72
  • From 1 Oct 2021 to the primary completion date, 30 Jun 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Too sick to provide informed consent (based on clinician opinion)
  • Likely to be discharged in the next 48 hours (based on clinician opinion)

Who the study is looking for

  • 18+ years old
  • HIV-positive (by self-report or DCT result in UTH file)
  • Resident of Lusaka
  • Admitted to the hospital

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Teaching Hospital
Coordinator of this site? Confirm its status
LusakaZambiaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.